AlloSource announces first patients implanted with AlloWrap Amniotic Membrane in clinical study for two-level anterior cervical discectomy and fusion procedures
CENTENNIAL -- AlloSource announced the first patients have been enrolled in its clinical study titled, "A Randomized, Controlled Study to Evaluate Effectiveness of AlloWrap Amniotic Membrane for... Read More
Thursday February 25, 2021 0 comments
Essent Biologics launches to provide human-derived biomaterials and 3D biology data for cell therapy, tissue engineering
CENTENNIAL -- Essent Biologics today announced its launch as a new venture to meet the growing need for human-derived biomaterials and data to the regenerative medicine research community, as well... Read More
Wednesday January 27, 2021 0 comments
Science behind AlloSource Cryopreserved Cartilage published in med journal
CENTENNIAL -- AlloSource , one of the largest allograft providers in the U.S., announced the Journal of Orthopaedic Surgery and Research published the company's science in an article titled... Read More
Thursday December 10, 2020 0 comments
AlloSource names tendon and ligament portfolio under AlloConnex brand
CENTENNIAL -- AlloSource announced it is naming its tendon and ligament portfolio under the new brand AlloConnex. "Over the past 25 years, our offering of tendons and ligaments has grown, and... Read More
Monday July 27, 2020 0 comments
AlloSource: Research shows ProChondrix maintains high cell viability
CENTENNIAL -- AlloSource announced research results showing ProChondrix CR maintains consistent, high cell viability for two years when stored at -80̊ C. Allosource said the research found... Read More
Tuesday October 8, 2019 0 comments
AlloSource marks 25 years of doing more with life
CENTENNIAL -- AlloSource ,an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, announced it is celebrating 25 years of honoring donors and... Read More
Monday August 12, 2019 0 comments
AlloSource announces first patient enrolled in cartilage defect study
CENTENNIAL -- AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, announced it enrolled the first patient in a study titled A... Read More
Thursday March 21, 2019 0 comments
AlloSource: Tests show two-year shelf life for ProChondrix CR product
CENTENNIAL -- AlloSource , a company dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced ProChondrix CR now has a two-year shelf life based... Read More
Wednesday March 13, 2019 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
